US Stock MarketDetailed Quotes

DSNKY Daiichi Sankyo (ADR)

Watchlist
  • 25.272
  • +0.387+1.56%
15min DelayTrading Apr 29 12:06 ET
47.24BMarket Cap23.04P/E (TTM)

About Daiichi Sankyo (ADR) Company

Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

Company Profile

SymbolDSNKY
Company NameDaiichi Sankyo (ADR)
Founded2005
CEOMr. Sunao Manabe
MarketPink Market
Employees14887
Fiscal Year Ends03-31
AddressDaiichi Sankyo Head Office Bldg, A&B,3-5-1 Nihonbashi-honcho,Chuo-Ku
CityTokyo
ProvinceTokyo
CountryJapan
Zip Code103-8426
Phone81-3-6225-1111

Company Executives

  • Name
  • Position
  • Salary
  • Sunao Manabe
  • Executive Chairman of the Board and Chief Executive Officer
  • --
  • Takashi Matsumoto
  • Director, Managing Executive Officer, Chief Human Resources Officer and Head of Global HR
  • --
  • Hiroyuki Okuzawa
  • Director, President and Chief Operating Officer
  • --
  • Takashi Fukuoka
  • Director, Senior Executive Officer and Head, Global Corporate Strategy
  • --
  • Shoji Hirashima
  • Director, Senior Executive Officer and Head, Japan Business Unit
  • --
  • Kazuaki Kama
  • Chairman of the Board
  • --
  • Sawako Nohara
  • Independent Director
  • --
  • Yo Honma
  • Independent Director
  • --
  • Yasuhiro Komatsu
  • Independent Director
  • --
  • Takaaki Nishii
  • Independent Director
  • --

Market Insights

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More